EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy

Shivapriya Shivakumar, Nithin Kiran, Rohit Shetty, Pradhyumna Hulsermane Krishnamurthy, Arkasubhra Ghosh, Vrushali Deshpande, Nallathambi Jeyabalan

Indian Journal of Ophthalmology · 2026

DOI: 10.4103/ijo.ijo_2901_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Ophthalmology, 2026. Verfasst von Shivapriya Shivakumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka. Hauptthemen laut MEDLINE: Myopia, Atropine, Sclera, Dopamine. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Myopia is a complex refractive disorder and a leading cause of visual impairment worldwide. Inflammation plays a crucial role in the onset and progression of myopia. This study aimed to investigate the role of atropine in modulating inflammation-induced alterations in dopamine and its receptors in primary human scleral cells under in vitro experimental conditions.

Methods

Human primary scleral cells were exposed to long-term inflammatory conditions in the presence or absence of atropine or dopamine hydrochloride. Following treatment, gene and protein expressions were analyzed for inflammatory markers, dopamine receptors, and extracellular matrix (ECM) using quantitative polymerase chain reaction, immunoblotting, and immunofluorescence. Secretory cytokines and dopamine levels were measured using an automated enzyme-linked immunosorbent assay system.

Results

In primary human scleral cells, atropine treatment increases the dopamine receptor expression. Prolonged inflammatory stimulation led to a marked reduction in dopamine and its receptor (D1–D2) expression, which was effectively restored following atropine treatment in scleral cells. Under inflammatory conditions, atropine significantly suppressed pro-inflammatory cytokines expression at both the transcript and protein levels and mitigated the inflammation-induced dysregulation of ECM genes.

Conclusion

Our findings demonstrate atropine restores inflammation-induced dopaminergic and extracellular matrix dysregulation in human scleral cells, highlighting its dual anti-inflammatory and neuro-modulatory roles. The restoration of dopamine signaling and ECM balance underscores atropine’s potential as a therapeutic agent for myopia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyopiaAtropineScleraDopamineInflammationReceptors, DopamineGene Expression RegulationHumansCells, CulturedEnzyme-Linked Immunosorbent AssayMuscarinic AntagonistsCytokines

Stichwörter der Autor:innen

AtropineDATdopaminedopamine receptorsinflammationmyopia

Substanzen

AtropineDopamineReceptors, DopamineMuscarinic AntagonistsCytokines

Autor:innen und Institutionen

  • Grow Research Laboratory, Narayana Netralaya Foundation, Bangalore, Karnataka.
  • Faculty of Medicine and Life sciences, School of Mental Health and Neurosciences, Maastricht University, Maastricht, Netherlands.
  • Department of Cornea and Refractive Surgery, Narayana Nethralaya Eye Hospital, Bangalore, Karnatake, India.

Zitieren

APA

Shivakumar, S., Kiran, N., Shetty, R., Krishnamurthy, P. H., Ghosh, A., Deshpande, V., & Jeyabalan, N. (2026). Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy. Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_2901_25

Vancouver

Shivakumar S, Kiran N, Shetty R, Krishnamurthy PH, Ghosh A, Deshpande V, et al. Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy. Indian Journal of Ophthalmology. 2026. doi:10.4103/ijo.ijo_2901_25

BibTeX
@article{Shivakumar2026,
  author = {Shivakumar, Shivapriya and Kiran, Nithin and Shetty, Rohit and Krishnamurthy, Pradhyumna Hulsermane and Ghosh, Arkasubhra and Deshpande, Vrushali and Jeyabalan, Nallathambi},
  title = {Atropine reinstates inflammation-induced dysregulation of dopamine and its receptors in human scleral cells: Implications for myopia therapy},
  journal = {Indian Journal of Ophthalmology},
  year = {2026},
  doi = {10.4103/ijo.ijo_2901_25}
}
Kostenlos starten →